The Power of AI To Advance Digital Health Innovation

In this featured ADDS (Ametris Digital Data Summit) 2026 session, a multidisciplinary panel of experts from Pfizer, Mayo Clinic, the FDA, UCLA, and Ametris explores how artificial intelligence and machine learning are advancing the development, validation, and regulatory readiness of digital endpoints in clinical research. Whether you're a clinical researcher, digital health innovator, or regulatory specialist, this discussion is designed for anyone eager to see how industry leaders actually transform AI-driven insights into real-world applications. We move beyond theory to showcase practical breakthroughs, like using remote monitoring to expand immunotherapy access and employing home-based assessments to capture meaningful patient outcomes in conditions like Parkinson’s disease. View all four videos below to explore key scientific sessions, panel discussions, and a dedicated scientific poster showcase.